Evidence map›Paper›PMID 35995313›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Mask disinfection using atmospheric pressure cold plasma.

Ana Sainz-García, Paula Toledano, Ignacio Muro-Fraguas, Lydia Álvarez-Erviti, Rodolfo Múgica-Vidal, María López, Elisa Sainz-García, Beatriz Rojo-Bezares, Yolanda Sáenz, Fernando Alba-Elías

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cold Atmospheric Pressure Plasma Solutions for Sustainable Food Packaging.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ana Sainz-GarcíaDepartment of Mechanical Engineering, University of La Rioja, C/ San José de Calasanz 31, 26004 Logroño, La Rioja, Spain.
Paula ToledanoMolecular Microbiology Area, Center for Biomedical Research of La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, La Rioja, Spain.
Ignacio Muro-FraguasDepartment of Mechanical Engineering, University of La Rioja, C/ San José de Calasanz 31, 26004 Logroño, La Rioja, Spain.
Lydia Álvarez-ErvitiMolecular Neurobiology Area, Center for Biomedical Research of La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, La Rioja, Spain.
Rodolfo Múgica-VidalDepartment of Mechanical Engineering, University of La Rioja, C/ San José de Calasanz 31, 26004 Logroño, La Rioja, Spain.
María LópezMolecular Microbiology Area, Center for Biomedical Research of La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, La Rioja, Spain.
Elisa Sainz-GarcíaDepartment of Mechanical Engineering, University of La Rioja, C/ San José de Calasanz 31, 26004 Logroño, La Rioja, Spain.
Beatriz Rojo-BezaresMolecular Microbiology Area, Center for Biomedical Research of La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, La Rioja, Spain.
Yolanda SáenzMolecular Microbiology Area, Center for Biomedical Research of La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, La Rioja, Spain. Electronic address: ysaenz@riojasalud.es.
Fernando Alba-ElíasDepartment of Mechanical Engineering, University of La Rioja, C/ San José de Calasanz 31, 26004 Logroño, La Rioja, Spain. Electronic address: fernando.alba@unirioja.es.
Center for Biomedical Research of La Rioja · ESUniversidad de La Rioja · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMask usage has increased over the last few years due to the COVID-19 pandemic, resulting in a mask shortage. Furthermore, their prolonged use causes skin problems related to bacterial overgrowth. To overcome these problems, atmospheric pressure cold plasma was studied as an alternative technology for mask disinfection.

methodsDifferent microorganisms (Pseudomonas aeruginosa, Escherichia coli, Staphylococcus spp.), different gases (nitrogen, argon, and air), plasma power (90-300 W), and treatment times (45 seconds to 5 minutes) were tested.

resultsThe best atmospheric pressure cold plasma treatment was the one generated by nitrogen gas at 300 W and 1.5 minutes. Testing of breathing and filtering performance and microscopic and visual analysis after one and five plasma treatment cycles, highlighted that these treatments did not affect the morphology or functional capacity of the masks.

conclusionConsidering the above, we strongly believe that atmospheric pressure cold plasma could be an inexpensive, eco-friendly, and sustainable mask disinfection technology enabling their reusability and solving mask shortage.

Indexed as

COVID-19Plasma GasesArgonAtmospheric PressureDisinfectionEscherichia coliHumansNitrogenPandemicsArgonNitrogenPlasma GasesAntibacterial treatmentCold plasmaDisinfectionMaskPlasma treatment

Identifiers

PMID35995313
PMCPMC9389523
OpenAlexW4294668941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.